Erica Ingram
Psychiatric/Mental Health · Silver Spring, MDNPI 1306117692
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 289 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,610 and has fallen 59.7% since, to $649 in 2025. Among psychiatric/mental health clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$839
- Supernus Pharmaceuticals, Inc.$716
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$587
- Lundbeck LLC$444
- Otsuka America Pharmaceutical, Inc.$424
- Tris Pharma Inc$343
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,51099%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $839 |
| Supernus Pharmaceuticals, Inc. | 28 | $716 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $587 |
| Lundbeck LLC | 23 | $444 |
| Otsuka America Pharmaceutical, Inc. | 23 | $424 |
| Tris Pharma Inc | 20 | $343 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $297 |
| Alkermes, Inc. | 15 | $284 |
| Johnson & Johnson | 10 | $265 |
| Ironshore Pharmaceuticals Inc. | 10 | $257 |
| Corium, LLC | 8 | $211 |
| Neurocrine Biosciences, Inc. | 8 | $166 |
| Vanda Pharmaceuticals Inc. | 4 | $111 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Neos Therapeutics, LP | 5 | $94 |
| Orexo US, Inc. | 6 | $94 |
| Teva Pharmaceuticals USA, Inc. | 5 | $74 |
| Almatica Pharma LLC | 3 | $62 |
| Eisai Inc. | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 2 | $39 |
| Vertical Pharmaceuticals, LLC | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Alfasigma USA, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$376
- Dyanavel XR$121
- Quillichew ER$121
- Quillivant$121
How this compares
$5,564 in reported general payments places this provider in the 95th percentile of 1,461 psychiatric/mental health providers in Maryland.
Other psychiatric/mental health in Silver Spring
- Jason EliassaintSilver Spring$11K
- Uchechukwu IfejiSilver Spring$5K
- Kathryn NovakSilver Spring$5K
- Hara OyedejiOwings Mills$780K
- Ilya RozenbergGlen Burnie$572K
- Michelle WilliamsColumbia$158K
- Kristin ClemensGaithersburg$36K
- Antonio HeroldHavre de Grace$23K
- Paul KlaverweidenFruitland$17K
- Margaret WebbAberdeen$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.